Skip to main content

Advertisement

Log in

Comparative Outcomes of Bariatric Surgery in Patients With and Without Human Immunodeficiency Virus

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Paradoxically, advances in anti-retroviral therapy that has increased survival for patients with human immunodeficiency virus (HIV) have resulted in greater numbers of HIV+ patients developing other chronic diseases, including obesity. Little comparative literature exists detailing perioperative or metabolic outcomes of bariatric surgery in the HIV+ population compared to HIV negative (HIV−) controls.

Methods

This is a retrospective case-control study with both HIV+ (case) and HIV− control patients. Individuals undergoing sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) between January 1, 2006 and December 31, 2015 were included. HIV+ status was defined as any individual with documented history of HIV.

Results

Eleven HIV+ patients underwent RYGB or SG during the study period. After matching (1:5 HIV+: HIV−) both cohorts had similar mean age (42 years), gender distribution (63% female), and preoperative BMI (48 kg/m2), as well as comorbidities. There were no differences in postoperative length of stay, or all cause 30-day morbidity. There were 63.7% HIV+ and 76.4% with 1-year follow-up available. Both percent excess weight loss (56% HIV+ vs. 60% HIV−) and BMI (32 HIV+ vs. 34 kg/m2 HIV−) were similar in both groups. There were minimal changes to CD4 count or HIV viral load in the patients during the follow-up period.

Conclusion

Bariatric surgery is safe and feasible in HIV-infected population well controlled on anti-retroviral medication. The short-term surgical and metabolic outcomes are similar to HIV− controls with minimal effect on the CD4 count and viral load in HIV+ cohort for long-term follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279:450–4.

    Article  CAS  PubMed  Google Scholar 

  2. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853–60. https://doi.org/10.1056/NEJM199803263381301.

    Article  PubMed  Google Scholar 

  3. Enanoria WT, Ng C, Saha SR, et al. Treatment outcomes after highly active antiretroviral therapy: a meta-analysis of randomised controlled trials. Lancet Infect Dis. 2004;4:414–25. https://doi.org/10.1016/S1473-3099(04)01057-6.

    Article  CAS  PubMed  Google Scholar 

  4. Keithley JK, Duloy AMS, Swanson B, et al. HIV infection and obesity: a review of the evidence. J Assoc Nurses AIDS Care. 2009;20:260–74. https://doi.org/10.1016/j.jana.2009.02.006.

    Article  PubMed  Google Scholar 

  5. Shikuma CM, Zackin R, Sattler F, et al. Changes in weight and lean body mass during highly active antiretroviral therapy. Clin Infect Dis. 2004;39:1223–30. https://doi.org/10.1086/424665.

    Article  CAS  PubMed  Google Scholar 

  6. Montessori V, Press N, Harris M, et al. Adverse effects of antiretroviral therapy for HIV infection. CMAJ. 2004;170:229–38.

    PubMed  PubMed Central  Google Scholar 

  7. Henry K, Melroe H, Huebsch J, et al. Severe premature coronary artery disease with protease inhibitors. Lancet. 1998;351:1328. https://doi.org/10.1016/S0140-6736(05)79053-X.

    Article  CAS  PubMed  Google Scholar 

  8. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017;376:641–51. https://doi.org/10.1056/NEJMoa1600869.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Flancbaum L, Drake V, Colarusso T, et al. Initial experience with bariatric surgery in asymptomatic human immunodeficiency virus-infected patients. Surg Obes Relat Dis. 1:73–6. https://doi.org/10.1016/j.soard.2005.02.004.

  10. Shor-Posner G, Campa A, Zhang G, et al. When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort. J Acquir Immune Defic Syndr. 2000;23:81–8.

    Article  CAS  PubMed  Google Scholar 

  11. Jones CY, Hogan JW, Snyder B, et al. Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis. 2003;37(Suppl 2):S69–80. https://doi.org/10.1086/375889.

    Article  PubMed  Google Scholar 

  12. Amorosa V, Synnestvedt M, Gross R, et al. A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr. 2005;39:557–61.

    PubMed  Google Scholar 

  13. Shuter J, Chang CJ, Klein RS. Prevalence and predictive value of overweight in an urban HIV care clinic. J Acquir Immune Defic Syndr. 2001;26:291–7.

    Article  CAS  PubMed  Google Scholar 

  14. Tang AM, Graham NM, Chandra RK, et al. Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr. 1997;127:345–51.

    Article  CAS  PubMed  Google Scholar 

  15. Fabre-Mersseman V, Tubiana R, Papagno L, et al. Vitamin D supplementation is associated with reduced immune activation levels in HIV-1-infected patients on suppressive antiretroviral therapy. AIDS. 2014;28:2677–82. https://doi.org/10.1097/QAD.0000000000000472.

    Article  CAS  PubMed  Google Scholar 

  16. Razonable R, Estes L, Thompson G. Gastric bypass surgery and serum concentrations of zidovudine, lamivudine, and nelfinavir. Present Int Conf AIDS. 2002;7-12:14.

    Google Scholar 

  17. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115(12):956-61.

  18. Frank E Harrell J Hmisc: Harrell Miscellaneous, 2015. R package version 3.17–0.

  19. Sekhon JS Matching: multivariate and propensity score matching with balance optimization, 2013. R package version 48-3.4.

  20. R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2015.

    Google Scholar 

  21. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81. https://doi.org/10.1016/j.jbi.2008.08.010.

    Article  PubMed  Google Scholar 

  22. Brethauer SA, Kim J, Chaar M El, Papasavas P, Eisenberg D, Rogers A, Ballem N, Kligman M, Kothari S. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11(3):489–506. https://doi.org/10.1016/j.soard.2015.02.003

  23. Fazylov R, Soto E, Merola S. Laparoscopic gastric bypass surgery in human immunodeficiency virus-infected patients. Surg Obes Relat Dis. 2007;3:637–9. https://doi.org/10.1016/j.soard.2007.08.012.

    Article  PubMed  Google Scholar 

  24. Muzard L, Alvarez J-C, Gbedo C, et al. Tenofovir pharmacokinetic after sleeve-gastrectomy in four severely obese patients living with HIV. Obes Res Clin Pract. 2017;11:108–13. https://doi.org/10.1016/j.orcp.2016.06.004.

    Article  PubMed  Google Scholar 

  25. Selke H, Norris S, Osterholzer D, et al. Bariatric surgery outcomes in HIV-infected subjects: a case series. AIDS Patient Care STDs. 2010;24:545–50. https://doi.org/10.1089/apc.2010.0132.

    Article  PubMed  Google Scholar 

  26. Zivich S, Cauterucci M, Allen S, et al. Long-term virologic outcomes following bariatric surgery in patients with HIV. Obes Res Clin Pract. 2015;9:633–5. https://doi.org/10.1016/j.orcp.2015.09.002.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Fysekidis M, Cohen R, Bekheit M, et al. Sleeve gastrectomy is a safe and efficient procedure in HIV patients with morbid obesity: a case series with results in weight loss, comorbidity evolution, CD4 count, and viral load. Obes Surg. 2015;25:229–33. https://doi.org/10.1007/s11695-014-1350-7.

    Article  PubMed  Google Scholar 

  28. Eddy F, Elvin S, Sanmani L. Bariatric surgery: an HIV-positive patient’s successful journey. Int J STD AIDS. 2016;27(1):70. https://doi.org/10.1177/0956462415571971.

    Article  CAS  PubMed  Google Scholar 

  29. Alfa-Wali M, Seechurn S, Ayodeji O, Nelson M, Shariq O, Milella M, Thompson J, Kapembwa M. Outcomes of bariatric surgery in human immunodeficiency virus positive individuals: a single center experience. Minerva Chir. 2016;71(4):233–8.

  30. Crum-Cianflone NF, Roediger M, Eberly LE, et al. Obesity among HIV-infected persons: impact of weight on CD4 cell count. AIDS. 2010;24:1069–72. https://doi.org/10.1097/QAD.0b013e328337fe01.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Damouche A, Lazure T, Avettand-Fènoël V, et al. Adipose tissue is a neglected viral reservoir and an inflammatory site during chronic HIV and SIV infection. PLoS Pathog. 2015;11:e1005153. https://doi.org/10.1371/journal.ppat.1005153.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthew Kroh.

Ethics declarations

Conflict of Interest

Gautam Sharma has no financial ties or financial disclosures pertinent to this work.

Andrew T Strong has no financial ties or financial disclosures pertinent to this work.

Mena Boules has no financial ties or financial disclosures pertinent to this work.

Chao Tu has no financial ties or financial disclosures pertinent to this work.

Samuel Szomstein has no financial ties or financial disclosures pertinent to this work.

Raul Rosenthal has no financial ties or financial disclosures pertinent to this work. He has received educational grant from Karl Storz, Medtronic, and Ethicon.

John Rodriguez has no financial ties or financial disclosures pertinent to this work. He has received research funding from Pacira Pharmaceuticals and Intuitive Surgical.

Alan Taege has no financial ties or financial disclosures pertinent to this work. He is a speaker for Gilead Sciences.

Matthew Kroh has no financial ties or financial disclosures pertinent to this work. He has serves as a consultant to Medtronic, Levita Magnetics, and Cook and has received research funding from Cook.

Ethical Approval Statement

For this type of study, formal consent is not required.

Informed Consent Statement

This study does not require informed consent.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sharma, G., Strong, A.T., Boules, M. et al. Comparative Outcomes of Bariatric Surgery in Patients With and Without Human Immunodeficiency Virus. OBES SURG 28, 1070–1079 (2018). https://doi.org/10.1007/s11695-017-2996-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-017-2996-8

Keywords

Navigation